drugset
drugset / Trial / NCT00426296

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

NCT00426296 ↗

Phase 4 Unknown Clinical Alliance for Research & Education - Infectious Diseases, LLC. GlaxoSmithKline · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

SHARE: Simple HAART with Abacavir, Reyataz, and Epivir

Timeline

Start
2006-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Atazanavir Other / unclassified 400 mg —
Background Ritonavir Other / unclassified 100 mg —

Indications

HIV infectious disease lipodystrophy